Nektar Therapeutics
NKTR
#6523
Rank
โ‚น66.32 B
Marketcap
โ‚น3,261
Share price
-3.99%
Change (1 day)
219.86%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น688.07

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น719.10. In 2024 the company made an earnings per share (EPS) of -โ‚น799.40 an increase over its 2023 EPS that were of -โ‚น1,976.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น688.07-13.93%
2024-โ‚น799.40-59.54%
2023-โ‚น1,976-25.89%
2022-โ‚น2,666-31.12%
2021-โ‚น3,87114.86%
2020-โ‚น3,370-1.19%
2019-โ‚น3,411-163.96%
2018โ‚น5,332-725.4%
2017-โ‚น852.64-42.73%
2016-โ‚น1,48983.33%
2015-โ‚น812.0339.53%
2014-โ‚น581.96-69.29%
2013-โ‚น1,895-6.67%
2012-โ‚น2,030

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น941.91-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.19-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,176-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น59.55-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น685.16-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น482.71-167.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น6.32-100.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น186.77-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland